News & Updates
Filter by Specialty:
Composite metric boosts tapinarof efficacy for AD
20 Mar 2025
byAudrey Abella
Two pivotal phase III trials show that a once-daily application of tapinarof cream 1% yields rapid treatment response – as indicated by the vIGA-AD™×BSA* composite score – in individuals with moderate-to-severe atopic dermatitis (AD).
Composite metric boosts tapinarof efficacy for AD
20 Mar 2025
Long-term oral progestogen therapy effective, well tolerated in endometriosis management
19 Mar 2025
byDr. Tak-Keung Sum, Specialist in Obstetrics and Gynaecology, Private practice, Hong Kong
Endometriosis is a chronic disease, which requires interventions that are both effective and well tolerated in the long term. Dr Tak-Keung Sum, Specialist in Obstetrics and Gynaecology in private practice in Hong Kong, reviews clinical and real-world evidence on the long-term efficacy and safety of an oral progestogen, dienogest (Visanne®, Bayer), and shares his personal experience in managing endometriosis across different patient profiles.
